Todd Chanko

The stock continues to tread water but we’re not ready to pull the plug on our former pick.

Negative headlines in France mask multiple growth opportunities for the stock.

Frontline can rally 38%, supported in part by growing supply from non–Middle East sources.

Shares of the fund administrator could rally by 27%.

SPS Commerce has recovered almost all SaaSpocalypse losses and is poised to rally further from here.

Amadeus has grown revenue and earnings despite several headwinds.

Medpace has carved out a niche helping smaller biotechs navigate the regulatory process.

GigaCloud has built a profitable niche in oversize e-commerce, pairing rapid earnings growth with an asset-light logistics model that could still leave room for the stock to climb.

Publicis is pairing AI-powered marketing with strong client retention, growing free cash flow, and a major data acquisition. Despite outperforming peers, the shares still trade at a discount.

First Advantage is growing market share in the lucrative personal verification market.

Management is delivering on its plan to expand into healthcare technology.

The stock is down 25% since our pick but we aren’t willing to wave the white flag quite yet.

Expansion into high-tech audio, fire protection, and even medical devices has the company poised for growth that isn’t reflected in its stock price.

The stock can supply portfolios with their own long-term care.

The stock has room to rebound even further, and is a buy at these levels.

The company’s history of innovation, earnings trajectory, and growth drivers makes its stock a buy.

Earnings momentum, pricing power, and barriers to entry can help the alloy manufacturer’s stock advance 42% from here.

The stock can double from here as cost savings from AI and other strategic initiatives pay off.

The stock is up 66% since Barron’s Investor Circle picked it.

The stock can rally by 75% or more in the coming 12 months.